AI Insights · Timothy · April 2022
Top 5 Medical Apps on Android in Russia: Q1 2022 Performance
Discover the performance trends of the top 5 medical apps on the Android platform in Russia for Q1 2022, including downloads, revenue, and active users.
In the first quarter of 2022, the top 5 medical apps on the Android platform in Russia showcased varied performance trends in downloads, revenue, and active users. Here’s a detailed look at their metrics based on data from Sensor Tower.
МедикТест (Аккредитация 2024) saw a significant increase in weekly downloads, peaking at approximately 3K in the last week of March. The weekly revenue trend for the app reached its highest at around $1K in early February, before declining to $252 in the first week of March. Active users also grew steadily, starting from 14.1K at the end of December and reaching 17.8K by the end of March.
Anatomy 3D Atlas experienced a steady weekly download rate, with numbers fluctuating between 947 and 1.3K throughout the quarter. The app's weekly revenue peaked at $662 in mid-January but saw a decline to just $86 by early March. Active users showed a slight decline from 4.1K in early January to 3.3K by the end of March.
Anatomy Learning - 3D Anatomy maintained a consistent download rate, peaking at 1.1K in the last week of March. The app's weekly revenue reached its highest at $528 in early February, before dropping to $58 in the first week of March. Active users increased from 3.3K at the end of December to 3.7K by the end of March.
Easy anatomy. Medical atlas showed a steady increase in weekly downloads, peaking at 1.4K in the first week of March. The weekly revenue trend for this app saw its highest point at $330 in mid-January, declining to $40 by early March.
Lastly, Учи Мед (Учи Анат) had a less dynamic quarter with no recorded downloads. The app's weekly revenue fluctuated, reaching a high of $193 in early February before dropping to $66 in the first week of March.
These insights provide a snapshot of how these medical apps performed in Russia during Q1 2022. For a more detailed analysis, visit Sensor Tower.